The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.

Source:http://linkedlifedata.com/resource/pubmed/id/21332653

Download in:

View as

General Info

PMID
21332653